Immix Biopharma, Inc. — Director's Dealing 2021

Dec 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immix Biopharma, Inc. (IMMX)
CIK: 0001873835
Period of Report: 2021-12-20

Reporting Person: Torchilin Vladimir P (Scientific Co-Founder)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-12-17	Common Stock	P	2200	$4.47	Acquired	902200	Direct
2021-12-20	Common Stock	P	3000	$5.00	Acquired	905200	Direct